Rock Springs Capital Management LP Q4 2019 Filing

Filed February 14, 2020

Portfolio Value

$3.2B

Holdings

130

Report Date

Q4 2019

Filing Type

13F-HR

All Holdings (130 positions)

StockValue
NGMUSDNGM BIOPHARMACEUTICALS INC
$6.5M
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
$6.1M
$5.8M
CHIASMA INC
$5.8M
HCATHEALTH CATALYST INC
$5.6M
TXG10X GENOMICS INC
$5.5M
RTI SURGICAL HOLDINGS INC
$5.3M
SPROSPERO THERAPEUTICS INC
$5.0M
AKROAKERO THERAPEUTICS INC
$5.0M
GLOBAL CORD BLOOD CORPORATIO
$4.6M
GAMIDA CELL LTD
$4.3M
BLUEBIRD BIO INC
$3.1M
ACRSACLARIS THERAPEUTICS INC
$3.0M
OBSEVA SA
$3.0M
NABRIVA THERAPEUTICS PLC
$2.8M
MGNXMACROGENICS INC
$2.5M
ANABANAPTYSBIO INC
$2.2M
FIVE PRIME THERAPEUTICS INC
$1.8M
THERAVANCE BIOPHARMA INC
$1.6M
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC
$1.5M
PARATEK PHARMACEUTICALS INC
$1.5M
RADIUS HEALTH INC
$1.3M
PACIRA BIOSCIENCES
$1.0M
ADAPYADAPTIMMUNE THERAPEUTICS PLC
$960K
DERMIRA INC
$925K
CRVSCORVUS PHARMACEUTICALS INC
$816K
BMY-RBRISTOL MYERS SQUIBB CO
$557K
APLTAPPLIED THERAPEUTICS INC
$554K
PFEPFIZER INC
$407K
CVETUSDCOVETRUS INC
$273K
PreviousPage 2 of 2